TAP Pharmaceuticals is planning to launch an over-the-counter version of Prevacid - Brief Article

Drug Cost Management Report, July 25, 2003

> * TAP Pharmaceuticals is planning to launch an over-the-counter version of Prevacid, to be called Prevocat. TAP is a joint venture between Abbott Labs and Takeda Chemical Industries. The company claims that the recent launch of generic Prilosec (omeprazole) has had minimal impact on Prevacid sales, and says Prevacid has maintained a 30% market share thanks to a direct-to-consumer marketing campaign during the second quarter.